K31.82
Dieulafoy lesion (hemorrhagic) of stomach and duodenum
Clinical Classification Guidelines
Excludes Type 2
- Dieulafoy lesion of intestine (K63.81)
Medical Intelligence & Overview
A Dieulafoy lesion is a rare but significant cause of gastrointestinal bleeding, primarily affecting the stomach and duodenum. It involves an abnormal, enlarged artery located just beneath the lining of these parts of the digestive tract. The lesion can cause severe bleeding without any prior warning signs, making it a critical condition requiring prompt diagnosis and management. Despite its rarity, recognizing a Dieulafoy lesion is vital because it can lead to life-threatening hemorrhages if untreated.
Causes & Symptoms
Clinical Causes: Degeneration of the blood vessel wall leading to an enlarged, tortuous artery close to the mucosal surface. Erosion of the overlying mucosa, exposing the underlying artery. Age-related vascular changes, often seen in middle-aged and older adults. Certain medical conditions like hypertension or cardiovascular disease that affect blood vessels. Potential associations with chronic gastrointestinal conditions, though often idiopathic.
Key Symptoms: Sudden and severe gastrointestinal bleeding. Vomiting blood, which may appear bright red or in a coffee-ground appearance. Passing of black, tarry stool (melena). Signs of anemia such as weakness, fatigue, and dizziness due to blood loss. Less commonly, abdominal pain or discomfort, though bleeding is often the predominant symptom.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of a Dieulafoy lesion involves various procedures aimed at visualizing the bleeding site. These include:
Treatment Protocols: Management of a Dieulafoy lesion focuses on controlling bleeding and preventing recurrence. Typical approaches include:
Clinical Advice & FAQs
Billing Guidance
Is K31.82 a billable ICD-10 code?
Yes, K31.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K31.82?
Clinical documentation must specify the nature of Dieulafoy lesion (hemorrhagic) of stomach and duodenum and any associated comorbidities for accurate reporting.
Cite this Clinical Reference